News
Mednax 2Q earnings climb 14 pct to $49.4 million
August 3, 2010 7:45 am | by The Associated Press | CommentsNational physician group Mednax Inc. said Tuesday its second-quarter earnings climbed 14 percent, as contributions from newly acquired doctor practices helped boost revenue.Mednax earned $49.4 million, or $1.04 per share, in the three months that ended June 30. That compares to earnings of...
Tenet turns 2Q profit on greater revenue per visit
August 3, 2010 7:45 am | by The Associated Press | CommentsHospital operator Tenet Healthcare Corp. on Tuesday reported a profit in the second quarter as it received more revenue per patient visit.Tenet posted net income of $25 million, or 5 cents per share. That compares with a loss of $15 million, or 3 cents per share, one year ago. Revenue rose 3...
Sun Healthcare Group offering 19.3 million shares
August 3, 2010 7:45 am | by The Associated Press | CommentsHealth care facility operator Sun Healthcare Group Inc. said Tuesday it is publicly offering 19.3 million shares of common stock.The company will also give underwriters a 30-day option to buy up to 2.9 million additional shares of stock to cover any overallotments. Sun said it would use the...
PerkinElmer acquires imaging tech firm VisEn Medical
August 3, 2010 7:36 am | by Mass High Tech: The Journal of New England Technology | CommentsPerkinElmer Inc., a Waltham provider of equipment and services to support human and environment health, has bought Bedford molecular imaging technology company VisEn Medical Inc.
AACR Hosts Molecular Diagnostics Conference in Denver, Colo.
August 3, 2010 7:34 am | by AACR | CommentsThis year, the American Association for Cancer Research will host its fourth Molecular Diagnostics in Cancer Therapeutic Development: Challenges and Horizons conference at the Sheraton Denver Downtown Hotel in Denver, Colo. This meeting regularly draws representatives from academia and...
Idera pulling in $15M financing
August 3, 2010 6:36 am | by Mass High Tech: The Journal of New England Technology | CommentsIdera Pharmaceuticals Inc. is raising $15 million in a registered direct offering the Cambridge biotech has made with investors.
Accuray's CyberKnife G4 System Receives Shonin Approval
August 3, 2010 6:35 am | by Bio-Medicine.Org | CommentsSUNNYVALE, Calif. , Aug. 3 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today it received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market the CyberKnife® G4 Robotic Radiosurgery System to...
Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity
August 3, 2010 6:34 am | by Bio-Medicine.Org | CommentsSAN DIEGO , Aug. 3 /- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) announced the online publication of results from its COR-BMOD trial of Contrave® (naltrexone SR/bupropion SR) in the journal Obesity . The COR-BMOD trial evaluated intensive behavior modification (BMOD) plus...
Volcano Corporation Presentation at Canaccord Genuity Growth Conference to be Webcast
August 3, 2010 6:34 am | by Bio-Medicine.Org | CommentsSAN DIEGO , Aug. 3 /- Volcano Corporation (Nasdaq: VOLC ), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the...
Sirona Dental 3Q net income falls 19 percent
August 3, 2010 5:45 am | by The Associated Press | CommentsDental equipment maker Sirona Dental Systems Inc. said Tuesday its fiscal third-quarter net income fell 19 percent on higher expenses.The company reported net income of $16.6 million, or 29 cents per share, for the three months ended June 30, down from $20.5 million, or 37 cents per share, a...
Genzyme reportedly in buyout talks with Sanofi
August 3, 2010 5:36 am | by Mass High Tech: The Journal of New England Technology | CommentsGenzyme Corp. and French drug maker Sanofi-Aventis are in talks over a possible sale, according to several reports. The news comes after weeks of speculation, prompted first by comments from Sanofi CEO Chris Viehbacher that it was in the market to buy a company worth about $20 billion.
FDA Summary of Safety and Effectiveness Data (SSED) Clinical Section Checklist
August 3, 2010 5:31 am | by U.S. Food & Drug Administration | CommentsThe Summary of Safety and Effectiveness (SSED) is a document mandated by the Food, Drug and Cosmetic Act subparagraph 520(h)(1)(A) to be publicly available upon issuance of an approval order of a premarket approval application (PMA).
Federal Register: Medical Device User Fee Rates for Fiscal Year 2011
August 3, 2010 5:31 am | by U.S. Food & Drug Administration | CommentsThe FDA is announcing the fee rates and payment procedures for medical device user fees for fiscal year (FY) 2011. The Federal Food, Drug, and Cosmetic Act (the act), as amended by the Medical Device User Fee Amendments of 2007 (title II of the Food and..
AACR to Ring Opening Bell at NASDAQ Stock Market
August 3, 2010 4:35 am | by AACR | CommentsPHILADELPHIA – The American Association for Cancer Research's Chief Executive Officer, Margaret Foti, Ph.D., M.D. (h.c.), along with other AACR representatives, will ring the opening bell at the NASDAQ Stock Market on Tuesday, August 3, signaling the start of the day's trading. The...
China Pharma Holdings, Inc. to Report Second Quarter 2010 Financial Results on August 10, 2010
August 3, 2010 4:35 am | by Bio-Medicine.Org | CommentsHAIKOU CITY, China , Aug. 3 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI ), which develops, manufactures, and markets specialty pharmaceutical products in China , today announced that it plans to release its second quarter 2010 financial...
